Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort

International Journal of Colorectal Disease

Volumn 28, Issue 6, 2013, Pages 829-834

  Matsuoka, Hiroki ^a,b   Ikeuchi, Hiroki ^a,b   Uchino, Motoi ^a,b   Bando, Toshihiro ^a,b   Takesue, Yoshio ^c   Nishigami, Takayuki ^d   Tomita, Naohiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Inflammatory Bowel Disease Center   (Japan)

^c Department of Infection Control and Prevention ^*  (Japan)

^d Steel Memorial Hirohata Hospital   (Japan)

Author keywords

Surveillance colonoscopy; Survival rate; Ulcerative colitis; Ulcerative colitis associated colorectal cancer

Indexed keywords

CORTICOSTEROID; MESALAZINE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SIGMOIDOSCOPY; SURVEILLANCE COLONOSCOPY; SURVIVAL RATE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POPULATION SURVEILLANCE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84878615900     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1592-6     Document Type: Article

References (22)

1. Ekbom A, Heimick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 323:1228-1233
2. Van Staa TP, Card T, Logan RF, Logan RF, Leufkens HG (2005) 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54:1573-1578
3. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641-1657
4. Byers T, Levin B, Rothenberger DA, Dodd GD, Smith RA (1997) American cancer society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American cancer society detection and treatment advisory group on colorectal cancer. CA Cancer J Clin 47:154-160
5. Watanabe T, Konishi T, Kishimoto J et al (2011) Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 17:802-808
6. Truelove SC, Witts LJ (1995) Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 24947:1041-1048
7. Heimann TM, Greenstein AJ, Bolnick K, Yoelson S, Aufses AH (1985) Colorectal cancer in familial polyposis and ulcerative colitis. Dis Colon Rectum 28:658-661
8. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526-535
9. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107:117-120
10. Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451-459
11. Rubin DT, Cruz-correa MR, Gasche C et al (2008) Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis 14:265-274
12. Velayos FS, Terdiman JP, Walsh JM (2005) Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 100:1345-1353
13. Chan EP, Lichtenstein GR (2006) Chemoprevention risk reduction with medical therapy of inflammatory bowel disease. Gastroenterol Clin North Am 35:675-712
14. Bernstein CN, Nugent Z, Blanchard JF (2011) 5-Aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Am J Gastroenterol 106:731-736
15. Baars JE, Looman CW, Steyerberg EW et al (2011) The risk of inflammatory bowel disease-related colorectal carcinoma is limited result from a nationwide nested case-control study. Am J Gastroenterol 106:319-328
16. Actis GC, Pellicano R, David E, Sapino A (2010) Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast. Inflamm Allergy Drug Targets 9:6-9
17. Rubin DT (2006) The changing face of colorectal cancer in inflammatory bowel disease: progress at least! Gastroenterology 130:1350-1352
18. Chambers WM, Warren BF, Jewell DP, Mortensen NJ (2005) Cancer surveillance in ulcerative colitis. Br J Surg 92:928-936
19. Ohman U (1982) Colorectal carcinoma in patients with ulcerative colitis. Am J Surg 144:344-349
20. Jensen AB, Larsen M, Gislum M et al (2006) Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol 101:1283-1287
21. Lavery IC, Chiulli RA, Jagelman DG, Fazio VW, Weakley FL (1982) Survival with carcinoma arising in mucosal ulcerative colitis. Ann Surg 195:508-512
22. Sugita A, Greenstein AJ, Ribeiro MB et al (1993) Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg 218:189-195